Review ■ : Insulin-like Growth Factor-I and Apoptosis in Glial Cell Biology

Abstract

Insulin-like growth factor-I (IGF-I) is a potent trophic factor capable of promoting both survival and differentiation of neurons and glia. This review examines the role of IGF-I and apoptosis in oligodendrocyte and Schwann cell biology in vitro and in vivo. Apoptosis is an essential element of development, homeostasis, and disease. IGF-I protects oligodendrocytes and Schwann cells from apoptosis during development and after apoptotic stimuli. Transgenic mouse models, which ablate or increase expression of IGF-I, have abnormal oligodendrocytes and myelin formation. A more thorough understanding of the protective mechanism of IGF-I in oligodendrocytes and Schwann cells will aid in its precise application in treating a variety of neurologic disorders. NEUROSCIENTIST 6:39-47, 2000

Keywords

Schwann cell,Oligodendrocyte,Apoptosis,Myelin,Insulin-like growth factor-I (IGF-I),Glia

Get full access to this article

View all access options for this article.

References

Rotwein P

Structure, evolution, expression and regulation of insulin-like growth factors I and II

Growth Factors 1991,5 3-18

De Meyts P , Wallach B , Christoffersen CT , Urso B , Gronskov K , Latus LJ , et al The insulin-like growth factor-I receptor Structure, ligand-binding mechanism and signal transduction . Horm Res 1994,42 152-69

Beck F , Samam NJ , Byrne S , Morgan K , Gebhard R , Brammar WJ

Histochemical localization of IGF-I and IGF-II mRNA in the rat between birth and adulthood

Development 1988,104 29-39

Stylianopoulou F , Herbert J , Soares MB , Efstratiadis A Expression of the msulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci U S A 1988,85 141-5

Lee JE , Pintar J , Efstratiadis A Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 1990 ,110 151-9

Van Evercooren AB , Olichon-Berthe C Expression of IGF-I and insulin receptor genes in the rat central nervous system a developmental, regional, and cellular analysis. J Neurosci Res 1991 ,28 244-53

Adem A , Jossan SS , d'Argy R , et al Insulin-like growth factor 1 (IGF-1) receptors in the human brain. quantitative autoradiographic localization Bram Res 1989 ;503.299-303

Sara VR , Carlsson-Skwirut C , Andersson C , Hall E , Sjogren B , Holmgren A , et al Characterization of somatomedins from human fetal brain identification of a variant form of insulin-like growth factor I Proc Natl Acad Sci U S A 1986,83 4904-7

Roth RA. Structure of the receptor for insulin-like growth factor II the puzzle amplified Science 1988,2391269-71

10.

Bondy C , Werner H , Roberts CT Jr , LeRoith D

Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain comparison with insulin-like growth factors I and II

Neuroscience 1992,46.909-23

11.

MacDonald RG

Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes

Endocrinology 1991;128.413-421

12.

Gammeltoft S , Haselbacher GK , Humbel RE , Fehlmann M , Van Obberghen E

Two types of receptor for insulin-like growth factors in mammalian brain

EMBO J 1985,4 3407-12.

13.

Sklar MM , Thomas CL , Municchi G , Roberts CT Jr , LeRoith D , Kiess W , et al. Developmental expression of rat insulin-like growth factor-II/mannose 6-phosphate receptor messenger ribonucleic acid Endocrinology 1992 ;130:3484-91

14.

Sklar MM , Kies W , Thomas CL , Nissley SP

Developmental expression of the tissue insulin-like growth factor II/mannose 6-phosphate receptor in the rat

J Biol Chem 1989;264 16733-8

15.

Bondy CA , Werner H , Roberts CT Jr , LeRoith D Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis. comparison with IGF-II gene expression Mol Endocrinol 1990,4.1386-98

16.

Leventhal PS , Russell JW , Feldman EL IGFs and the nervous system In. Rosenfeld RG , Roberts CT Jr , editors Contemporary endocnnology : the IGF system Totowa (NJ) Humana Press, 1999. p 425-55

17.

Ashkenazi A , Dixit VM

Death receptors. signaling and modulation

Science 1998;281 1305-8

18.

Thornberry NA , Lazebnik Y

Caspases enemies within

Science 1998,281 1312-6

19.

Probst-Cousin S , Rickert CH , Schmid KW , Gullotta F

Cell death mechanisms in multiple system atrophy

J Neuropathol Exp Neurol 1998 ,57.814-21

20.

Lassmann H , Bancher C , Breitschopf H , Wegiel J , Bobinski M , Jellmger K , et al Cell death m Alzheimer's disease evaluated by DNA fragmentation in situ Acta Neuropathol 1995,89.35-41

21.

Dowling P , Husar W , Menonna J , Donnenfeld H , Cook S , Sidhu M

Cell death and birth in multiple sclerosis brain

J Neurol Sci 1997,149 1-11

22.

22 Feldman EL , Windebank AJ Growth factors and peripheral neuropathy In Dyck PJ , Thomas PK , editors Diabetic neuropathy 2nd ed Philadelphia W B Saunders, 1999 p 377-86.

23.

Erdem S , Mendell JR , Sahenk Z Fate of Schwann cells m CMT1A and HNPP evidence for apoptosis. J Neuropathol Exp Neurol 1998,57 635-42

24.

Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.

25.

Barres BA , Hart IK , Coles HS , Bume JF , Voyvodic JT , Richardson WD , et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992;70:31-46.

26.

Selmaj K , Raine CS , Farooq M , Norton WT , Brosnan CF. Cytokme cytotoxicity against oligodendrocytes. J Immunol 1991;147: 1522-9.

27.

Vartanian T , Goodearl A , Viehöver A , Fischbach G. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J Cell Biol 1997;137:211-20.

28.

Larocca JN , Farooq M , Norton WT. Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem Res 1997;22:529-34.

29.

Richter-Landsberg, C Vollgraf U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp Cell Res 1998;244:218-229.

30.

Hisahara S , Shoji S , Okano H , Miura M. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 1997;69:10-20.

31.

Gu C , Casaccia-Bonnefil P , Srimvasan A , Chao MV. Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci 1999;19:3043-9.

32.

Akassoglou K , Bauer J , Kassiotis G , Pasparakis M , Lassmann H , Kollias G , et al. Oligodendrocyte apoptosis and primary demyelmation induced by local TNF/p55TNF receptor signaling m the central nervous system of transgenic mice. Am J Pathol 1998;153:801-13.

33.

Skoff RP. Programmed cell death in the dysmyelinatmg mutants. Brain Pathol 1995;5:283-8.

34.

Lipsitz D , Goetz BD , Duncan ID. Apoptotic glial cell death and kinetics in the spinal cord of the myelin-deficient rat. J Neurosci Res 1998;51:497-507.

35.

Mandai K , Matsumoto M , Kitagawa K , Matsushita K , Ohtsuki T , Mabuchi T , et al. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia Neuroscience 1997;77:849-61.

36.

Shuman SL , Bresnahan JC , Beattie MS. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 1997;50:798-808.

37.

Pender MP , Nguyen KB , McCombe PA , Kerr JF. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991;104:81-7

38.

McMorris FA , Mozell RL , Carson MJ , Shmar Y , Meyer RD , Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci 1993;692:321-334.

39.

McMorris FA , Smith TM , DeSalvo S , Furlanetto RW. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A 1986;83:822-6.

40.

Masters BA , Werner H , Roberts CT Jr , LeRoith D , Raizada MK. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains. Regul Pept 1991;33:117-31.

41.

Vemuri GS , McMorris FA. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development 1996;122:2529-37.

42.

Cho KH , Kim MW , Kim SU.

Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture

Dev Neurosci 1997;19:321-7.

43.

McDonald JW , Goldberg MP , Gwag BJ , Chi SI , Choi DW. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol 1996 ;40:750-8.

44.

Roth GA , Spada V , Hamill K , Bornstein MB. Insulin-like growth factor I increases myelmation and inhibits demyelmation m cultured organotypic nerve tissue. Brain Res Dev Brain Res 1995;88:102-8.

45.

Li W , Quigley L , Yao DL , Hudson LD , Brenner M , Zhang BJ , et al. Chronic relapsing expenmental autoimmune encephalomyelitis : effects of msulin-like growth factor-I treatment on climcal deficits, lesion seventy, glial responses, and blood brain barrier defects. J Neuropathol Exp Neurol 1998;57:426-38.

46.

Liu X , Yao DL , Webster J. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating autoimmune encephalomyelitis. Mult Scler 1995;1:2-9.

47.

Yao D-L , Liu X , Hudson LD , De F.Webster H Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 1995;92: 6190-4.

48.

Mirsky R , Jessen KR. The neurobiology of Schwann cells. Brain Pathol 1999;9:293-311.

49.

Jessen KR , Brennan A , Morgan L , Mirsky R , Kent A , Hashimoto Y , et al. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron 1994;12:509-27.

50.

Grinspan JB , Marchionni MA , Reeves M , Coulaloglou M , Scherer SS. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulm receptors and the role of neuregulins . J Neurosci 1996;16:6107-18.

51.

Nakao J , Shmoda J , Nakai Y , Murase S , Uyemura K. Apoptosis regulates the number of Schwann cells at the premyelinatmg stage . J Neurochem 1997;68:1853-62.

52.

Berciano MT , Calle E , Fernandez R , Lafarga M. Regulation of Schwann cell numbers in tellurium-induced neuropathy: apoptosis, supernumerary cells and internodal shortening. Acta Neuropathol 1998;95:269-79.

53.

Conti G , Scarpini E , Rostami A , Livraghi S , Baron PL , Pleasure D , et al. Schwann cell undergoes apoptosis during experimental allergic neuntis (EAN. J Neurol Sci 1998;161:29-35.

54.

Ekstrom PAR. Neurones and glial cell of the mouse sciatic nerve undergo apoptosis after injury in vivo and in vitro. Neuroreport 1995;6:1029-32.

55.

Kopp DM , Trachtenberg JT , Thompson WJ. Glial growth factor rescues Schwann cells of mechanoreceptors from denervation-induced apoptosis. J Neurosci 1997;17:6697-706.

56.

Scherer SS , Salzer JL. Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration. In: Richardson WD , Jessen KR. editors. Glial cell development. Oxford, UK: BIOS Scientific Publishers Limited; 1996. p. 165-96.

57.

Marchionni MA , Gnnspan JB , Canoll PD , Mahanthappa NK , Salzer JL , Scherer SS. Neuregulins as potential neuroprotective agents. Ann N Y Acad Sci 1997;825:348-65.

58.

Dong Z , Brennan A , Lm N , Yarden Y , Lefkowitz G , Mirsky R , et al. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat schwann cell precursors. Neuron 1995 ;15.585-96.

59.

Carroll SL , Miller ML , Frohnert PW , Kim SS , Corbett JA. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallenan degeneration. J Neurosci 1997;17:1642-59.

60.

Delaney CL , Cheng H-L , Feldman EL.

Insulin-like growth factor-I prevents caspase mediated apoptosis in Schwann cells

J Neurobiol, in press.

61.

Syroid DE , Zonck TS , Arbet-Engels C , Kilpatrick TJ , Eckhart W , Lemke G. A role for msulin-like growth factor-I in the regulation of Schwann cell survival . J Neurosci 1999;19:2059-68.

62.

Cheng HL , Randolph A , Yee D , Delafontaine P , Tennekoon G , Feldman EL. Characterization of insulin-like growth factor-I (IGF-I), IGF-I receptor and binding proteins in transected nerves and cultured schwann cells. J Neurochem 1996;66:525-36.

63.

Ishii DN Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 1995;40:138-44.

64.

Ishii DN , Glazner GW , Pu S-F. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther 1994;62:125-44.

65.

Zhuang HX , Synder CK , Pu SF , Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996; 140:198-205.

66.

D'Ercole AJ , Ye P , Calikoglu AS , Gutierrez-Ospma G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996;13:227-55.

67.

Ye P , Carson J , D'Ercole AJ. In vivo actions of msulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 1995;15:7344-56.

68.

Beck KD , Powell-Braxton L , Widmer H-R , Valverde J , Hefti F. Igfl gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-contammg neurons . Neuron 1995;14:717-30.

69.

Gao WQ , Shinsky N , Ingle G , Beck K , Elias KA , Powell-Braxton L. IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF- I treatment. J Neurobiol 1999;39:142-52.

70.

Yuen EC Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 1996 ;40:346-54.

71.

Hatton J , Rapp RP , Kudsk KA , Brown RO , Luer MS , Bukar JG , et al. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a Phase II safety and efficacy trial. J Neurosurg 1997;86:779-86.

72.

Chantelau E. Evidence that upregulation of serum IGF-I concentration can trigger acceleration of diabetic retmopathy. Br J Ophthalmol 1998;82:725-30.